NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The search is being carried out by a cybercrime unit in relation to an investigation opened in January 2025, the Paris prosecutor’s office said.Read More